- Home
- HI vs VCEL Comparison
HI vs VCEL Comparison
Compare HI & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HI
- VCEL
- Stock Information
- Founded
- HI 2007
- VCEL 1989
- Country
- HI United States
- VCEL United States
- Employees
- HI N/A
- VCEL N/A
- Industry
- HI Miscellaneous manufacturing industries
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HI Consumer Discretionary
- VCEL Health Care
- Exchange
- HI Nasdaq
- VCEL Nasdaq
- Market Cap
- HI 2.4B
- VCEL 2.8B
- IPO Year
- HI N/A
- VCEL 1997
- Fundamental
- Price
- HI $33.94
- VCEL $59.07
- Analyst Decision
- HI Buy
- VCEL Strong Buy
- Analyst Count
- HI 2
- VCEL 7
- Target Price
- HI $36.50
- VCEL $62.29
- AVG Volume (30 Days)
- HI 426.3K
- VCEL 424.2K
- Earning Date
- HI 02-03-2025
- VCEL 02-27-2025
- Dividend Yield
- HI 2.63%
- VCEL N/A
- EPS Growth
- HI N/A
- VCEL N/A
- EPS
- HI N/A
- VCEL 0.07
- Revenue
- HI $3,182,800,000.00
- VCEL $226,844,000.00
- Revenue This Year
- HI N/A
- VCEL $23.82
- Revenue Next Year
- HI $4.10
- VCEL $22.51
- P/E Ratio
- HI N/A
- VCEL $821.76
- Revenue Growth
- HI 12.63
- VCEL 22.48
- 52 Week Low
- HI $25.11
- VCEL $38.69
- 52 Week High
- HI $50.58
- VCEL $61.49
- Technical
- Relative Strength Index (RSI)
- HI 67.20
- VCEL 57.96
- Support Level
- HI $30.25
- VCEL $53.00
- Resistance Level
- HI $31.79
- VCEL $60.93
- Average True Range (ATR)
- HI 0.83
- VCEL 2.60
- MACD
- HI 0.38
- VCEL -0.06
- Stochastic Oscillator
- HI 91.38
- VCEL 76.54
About HI Hillenbrand Inc
Hillenbrand Inc is a U.S.-based company that operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment. The Molding Technology Solutions segment offers engineered and customized systems in plastic technology and processing. It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in various therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.